Structural basis of interaction between urokinase-type plasminogen activator and its receptor

被引:102
作者
Barinka, Cyril
Parry, Graham
Callahan, Jennifer
Shaw, David E.
Kuo, Alice
Bdeir, Khalil
Cines, Douglas B.
Mazar, Andrew
Lubkowski, Jacek [1 ]
机构
[1] NCI, Canc Res Ctr, Frederick, MD 21702 USA
[2] Attenuon, LLC, San Diego, CA 92121 USA
[3] DE Shaw Res & Dev, New York, NY 10036 USA
[4] Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
urokinase receptor; X-ray crystallography; protein/protein interactions; kringle domain; plasminogen;
D O I
10.1016/j.jmb.2006.08.063
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent studies indicate that binding of the urokinase-type plasminogen activator (uPA) to its high-affinity receptor (uPAR) orchestrates uPAR interactions with other cellular components that play a pivotal role in diverse (patho-)physiological processes, including wound healing, angiogenesis, inflammation, and cancer metastasis. However, notwithstanding the wealth of biochemical data available describing the activities of uPAR, little is known about the exact mode of uPAR/uPA interactions or the presumed conformational changes that accompany uPA/uPAR engagement. Here, we report the crystal structure of soluble urokinase plasminogen activator receptor (suPAR), which contains the three domains of the wild-type receptor but lacks the cell-surface anchoring sequence, in complex with the amino-terminal fragment of urokinase-type plasminogen activator (ATF), at the resolution of 2.8 angstrom. We report the 1.9 angstrom crystal structure of free ATF. Our results provide a structural basis, represented by conformational changes induced in uPAR, for several published biochemical observations describing the nature of uPAR/uPA interactions and provide insight into mechanisms that may be responsible for the cellular responses induced by uPA binding. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:482 / 495
页数:14
相关论文
共 58 条
[1]  
Andolfo A, 2002, THROMB HAEMOSTASIS, V88, P298
[2]  
APPELLA E, 1987, J BIOL CHEM, V262, P4437
[3]   The kringle stabilizes urokinase binding to the urokinase receptor [J].
Bdeir, K ;
Kuo, A ;
Sachais, BS ;
Rux, AH ;
Bdeir, Y ;
Mazar, A ;
Higazi, AAR ;
Cines, DB .
BLOOD, 2003, 102 (10) :3600-3608
[4]   A region in domain II of the urokinase receptor required for urokinase binding [J].
Bdeir, K ;
Kuo, A ;
Mazar, A ;
Sachais, BS ;
Xiao, WZ ;
Gawlak, S ;
Harris, S ;
Higazi, A ;
Cines, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28532-28538
[5]   Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G [J].
Beaufort, N ;
Leduc, D ;
Rousselle, JC ;
Magdolen, V ;
Luther, T ;
Namane, A ;
Chignard, M ;
Pidard, D .
JOURNAL OF IMMUNOLOGY, 2004, 172 (01) :540-549
[6]   Domain interplay in the urokinase receptor - Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains [J].
Behrendt, N ;
Ronne, E ;
Dano, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22885-22894
[7]  
BEHRENDT N, 1990, J BIOL CHEM, V265, P6453
[8]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[9]  
CASEY JR, 1994, BLOOD, V84, P1151
[10]   Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor [J].
Colman, RW ;
Pixley, RA ;
Najamunnisa, S ;
Yan, WY ;
Wang, JY ;
Mazar, A ;
McCrae, KR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1481-1487